Skip to main content
. Author manuscript; available in PMC: 2012 Sep 20.
Published in final edited form as: J Addict Med. 2012 Jun;6(2):159–165. doi: 10.1097/ADM.0b013e31824339fc

Table 1.

Physicians and their Practice and Patient Characteristics, n=382

Characteristic TOTAL (N=382)
Physician Race, %(n)
      American Indian or Alaska Native 1% (5)
      Asian 9% (35)
      African American 5% (19)
      Pacific Islander < 1% (1)
      White 76% (291)
      Others 6% (21)
Physician Hispanic ethnicity, %(n) 4% (15)
Physician male gender, %(n) 74% (283)
Physician certified addiction training, %(n) 28% (104)
Specialty (not mutually exclusive)
      Internal Medicine, %(n) 19% (74)
      Family practice, %(n) 34% (131)
      HIV/ID, % (n) 4% (15)
      Addiction medicine, %(n) 25% (97)
      Psychiatry, %(n) 32% (123)
Percent of time on patient treatment, mean (SD) 81%(22.5)
Years since graduation, mean (SD) 24.3 (11.1)
Years prescribing buprenorphine, %(n)
      ≤ 3 Years 72% (273)
      > 3 Years 28% (106)
Urban setting, %(n) 56% (216)
Addiction setting, %(n) 22% (83)
Treated >50 buprenorphine patients, %(n) 40% (149)
Percent of patients male, mean (SD) 61% (25)
Percent of patients white, mean (SD) 79% (27)
Percent of patients Hispanic, mean (SD) 8% (16)
Percent of patients age 18–40 years, mean (SD) 62% (28)
Percent uninsured, mean (SD) 18% (27)
Percent using prescription opioids, mean (SD) 64% (30)
Percent using intravenous heroin, mean (SD) 21% (26)